Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,995,725
+$2,097,450 QoQ
Shares Held
7,500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,318
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Unisphere Establishment holds $361,767,725 across 2 Drug Manufacturers - General names. LLY ranks #2 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
14,650,000 | $352,772,000 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
7,500 | $8,995,725 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,995,725 | 7,500 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,898,275 | 7,500 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,424,396 | 9,700 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,401,100 | 9,700 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,561,441 | 9,700 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,011,327 | 9,700 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,488,400 | 9,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,581,422 | 6,300 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||